Is it appropriate to tell adult patients with psychiatric disorders such as depression or anxiety that their symptoms are "all in their head"?

No—Telling Patients Their Psychiatric Symptoms Are "All in Your Head" Is Clinically Inappropriate and Harmful

You should never dismiss psychiatric symptoms as "all in your head" because depression and anxiety are legitimate medical disorders associated with increased mortality, heightened suicide risk, and severely impaired quality of life that require evidence-based treatment. 1

Why This Approach Is Harmful

Impact on Mortality and Morbidity

• Depression is associated with a 22-39% increased risk of premature mortality and an 18% increased risk of cancer death. 1
• Anxiety and depression significantly increase suicide risk, with documented elevated suicide rates among long-term cancer survivors and other populations with these disorders. 1
• Dismissive language creates barriers to treatment adherence, which is already problematic—patients with depression commonly lack motivation to follow through on referrals and treatment recommendations. 1

Prevalence and Severity

• Point prevalence estimates show 20.7% for any mood disorder, 10.3% for anxiety disorders, and 19.4% for adjustment disorders among patients with chronic illness, compared to 9.5% and 18.1% respectively in the general population. 1
• These disorders cause substantial functional impairment across major life areas, worsen physical symptoms, and increase healthcare costs. 1

The Correct Clinical Approach

Initial Assessment and Communication

• Provide culturally informed, linguistically appropriate education to patients and families about the commonality of depression and anxiety, their specific symptoms (cognitive, behavioral, physiologic), and signs of worsening that warrant immediate contact. 2
• Use validated screening tools such as the PHQ-9 for depression or GAD-7 for anxiety, or ask two simple questions: "Over the past 2 weeks, have you felt down, depressed, or hopeless?" and "Over the past 2 weeks, have you felt little interest or pleasure in doing things?" 3

Evidence-Based Treatment Selection

For moderate to severe depression: 4

• Offer monotherapy with either cognitive behavioral therapy (CBT) or a second-generation antidepressant as first-line treatment (strong recommendation, moderate-certainty evidence). 4
• Consider combination therapy with CBT plus a second-generation antidepressant based on patient preference, symptom severity, and treatment history. 4

For mild depression: 4

• Start with CBT monotherapy (conditional recommendation, low-certainty evidence). 4

For moderate to severe anxiety: 2

• Offer individual or group therapy with CBT, behavioral activation, structured physical activity, or psychosocial interventions with empirically supported components like relaxation and problem-solving. 2

Treatment Monitoring

• Assess treatment response regularly at 4 weeks, 8 weeks, and end of treatment using standardized validated instruments. 2
• After 8 weeks, if symptoms show little improvement despite good adherence, adjust the regimen by adding a psychological or pharmacologic intervention, switching medications, or referring from group to individual therapy. 2
• Monitor compliance biweekly or monthly, assess satisfaction with treatment, and construct plans to circumvent obstacles to adherence. 1

Common Pitfalls to Avoid

Risk Assessment Failures

• Always assess for risk of harm to self or others immediately—refer for emergency evaluation if present, facilitate a safe environment, and initiate harm-reduction interventions. 1
• Depression with comorbid anxiety (present in 50-60% of cases) requires treating the depression first in most circumstances. 1

Medical Causes

• First rule out and treat medical causes of depressive symptoms such as unrelieved pain, fatigue, delirium, infection, or electrolyte imbalance before attributing symptoms to primary psychiatric illness. 1

Dismissive Language Consequences

• Telling patients symptoms are "all in your head" reinforces stigma, reduces treatment-seeking behavior, and worsens outcomes by preventing access to effective interventions that can reduce mortality risk and improve quality of life. 1